Reserpine, besides its effects on the central nervous and cardiovascular system, has an important influence on the gastro-intestinal tract. This drug stimulates gastric secretion and motility ~-6 and increases the production of gastric hemorrhagic erosions after ligation of the pylorus in rats 7,~. It has been demonstrated that this substance releases serotonin from the brain and intestines 93°. The central nervous effects of reserpine are markedly changed after pretreatment with iproniazid, an inhibitor of monoamine oxidase, which prevents the decreases of serotonin in the brain by reserpine n,~z This suggests that the central pharmacological actions of reserpine might be due at least partly to alterations in the monoamine metabolism in the brain as.
Influence of Iproniazid Pretreatment on Formation of Gastric Ulcers by Reserpine in the Rat
Reserpine, besides its effects on the central nervous and cardiovascular system, has an important influence on the gastro-intestinal tract. This drug stimulates gastric secretion and motility ~-6 and increases the production of gastric hemorrhagic erosions after ligation of the pylorus in rats 7,~. It has been demonstrated that this substance releases serotonin from the brain and intestines 93°. The central nervous effects of reserpine are markedly changed after pretreatment with iproniazid, an inhibitor of monoamine oxidase, which prevents the decreases of serotonin in the brain by reserpine n,~z This suggests that the central pharmacological actions of reserpine might be due at least partly to alterations in the monoamine metabolism in the brain as.
The study of the influence of pretreatmcnt with iproniazid (Marsilid II) on the gastro-intestinal effects of reserpine might give additional informations on the working mechanism of reserpine.
In a first series of experiments, the possible inhibitory influence of iproniazid-pretreatment on the production of gastric erosions in the Shay-rat preparation was examined. 60 rats were divided in 3 groups. One group served as a control, a second group received 5 mg/kg reserpine intraperitoneally at the time of the ligation of the pylorus, and the third group was injected with iproniazid (100 mg/kg intraperitoneally 5 h before ligation of the pylorus) and reserpine (5 mg/kg at the time of pyloric ligation). Ligation of the pylorus was performed under light ether anesthesia. At least 48 h prior to operation ali food had been removed. Water was withheld from the time of operation until sacrifice. 7~/e h after the pylorus tigation, the rats were killed, their stomach removed, the accumulated gastric juice collected, and the gastric mucosa examined for ulcers or erosions.
The results show that iproniazid markedly inhibits the production of gastric hemorrhagic erosions by reserpine. Indeed, while all the animals which had received reserpine alone, showed hemorrhagic erosions of the glandular part of the stomach [antrum and (or) corpus] 71/2 h after pytorie ligation, no such lesions were observed in the reserpine animals which had been pretreated with iproniazid. The rats of the control group also did not show gastric erosions after the same time interval. The mean values of the pH, free acidity, and total volume of the collected gastric juice showed no significant difference between the reserpine group and the iproniazidreserpine groups.
It has been fuund that the serotonin precursor 5-hydroxytryptophan inhibits gastric acid secretion 14. Yet, consistently lesions of the glandular portion of the gastric mucosa were found in rats after a single injection of a high amount of this substancc~. Reserpine on the other hand, which decreases and liberates the serotonin in the gastro-intestinal tract, increases gastric acid secretion and ulcer formation. Iproniazid, which is known to interfere with the metabolism of the monoamines inhibits the productkm of gastric erosions by reserpine. The possibility exists that this protective effect depends on the interference of this substance with serotonin metabolism. 
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